In:
JCO Clinical Cancer Informatics, American Society of Clinical Oncology (ASCO), , No. 1 ( 2017-11), p. 1-6
Abstract:
Salvage radiotherapy (SRT) is the standard of care offered when postprostatectomy prostate-specific antigen (PSA) levels are ≥ 0.2 ng/mL. However, emerging evidence suggests that early SRT (ie, SRT delivered at PSA values 〈 0.2 ng/mL, but generally ≥ 0.05 ng/mL) improves oncologic outcomes. We evaluated the feasibility of improving referral rates for discussion of early SRT by using a dynamic registry that identifies through the electronic medical record patients with rising postprostatectomy PSA levels. Methods We developed an iteratively updated registry that identifies patients who fall within two postoperative PSA strata: ≥ 0.05 to 〈 0.1 ng/mL and ≥ 0.1 to 〈 0.2 ng/mL. We compared referral rates to radiation oncology during a 3-year period before use of this registry with those during a 1-year period after promotion of the registry in multidisciplinary tumor board settings. Results Before promotion of the registry, referral rates for patients with PSA values ≥ 0.05 to 〈 0.1 ng/mL and ≥ 0.1 to 〈 0.2 ng/mL were 35% and 65%, respectively. After promotion of the registry, referral rates within each stratum increased significantly to 82% and 94%, respectively ( P 〈 .05 for both by Fisher’s exact test). The overall rate of referral for patients with PSA values ≥ 0.05 to 〈 0.2 ng/mL rose from 48% to 90% ( P 〈 .001). Conclusion The creation of a registry of patients with rising postprostatectomy PSA values can facilitate increased referral rates for early SRT without burdening providers with a clinical support tool embedded within the EMR itself. This is true even in the case of already high baseline rates of referral for early SRT. The changes reported herein most likely reflect a Hawthorne effect wherein the ability to track referrals rather than a direct function of the registry influenced practice patterns. Nonetheless, the registry provided an integral framework to allow for tracking.
Type of Medium:
Online Resource
ISSN:
2473-4276
DOI:
10.1200/CCI.17.00046
Language:
English
Publisher:
American Society of Clinical Oncology (ASCO)
Publication Date:
2017
